
Neogen profits jump 33 percent
Neogen Corp. (NSDQ:NEOG) posted profits of $6.1 million, or 26 cents per diluted share, on sales of $43.9 million during the three months ended Nov. 30. That compares with profits of $4.6 million, or 20 cents per diluted share, on sales of $35.3 million during the same period last year.
Read more
Synergetics profits rise 17 percent despite even sales
Synergetics USA Inc. (NSDQ:SURG) reported profits of $633,000, or 3 cents per diluted share, on revenue of $12.08 million during the three months ended Oct. 31. That compares with profits of $542,000, or 2 cents per diluted share, on revenue of $12.17 million during the same period last year.
Read more
AngioDynamics profits, sales remain even
AngioDynamics Inc. (NSDQ:ANGO) posted net income of $3.3 million, or 13 cents per diluted share, on sales of $53.4 million during the three months ended Nov. 30. That compares with net income of $3.1 million, or 13 cents per diluted share, on sales of $53.5 million during the same period last year.
Read more
BSD Medical halves losses
BSD Medical Corp. (NSDQ:BSDM) recorded a loss of $947,301, or 4 cents per diluted share, on revenue of $506,985 during the three months ended Nov. 30. That compares with a loss of $1.9 million, or 9 cents per diluted share, on sales of $426,203 during the same period last year.
Read more
Biomet shaves off 6 percent from ’09 losses
Biomet Inc., a private company, reported a net loss of about $7.6 million on sales of $698.3 million during the three months ended Nov. 30. That compares with a net loss of $7.2 million on sales of $695.6 million during the same period last year.
Read more
SurModics net income dives into the red
SurModics Inc. (NSDQ:SRDX) recored a loss of $21.7 million, or $1.25 per diluted share, on revenue of $15.5 million during the three months ended Sept. 30. That compares with profits of $2.7 million, or 16 cents per diluted share, on revenue of $19.2 million during the same period last year.
Read more